 |
 |
|
|
RESÚMENES JUNIO 2005 |
Psychotic Disorders & Antipsychotics
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Mortality in Offspring of Parents With Psychotic Disorders: A Critical Review and Meta-Analysis
Roger Webb, Kathryn Abel, Andrew Pickles, and Louis A
Am J Psychiatry 162:1045-1056, June 2005
Zafiris J. Daskalakis, Bruce K. Christensen, Paul B. Fitzgerald, Sarah
I. Fountain, and Robert Chen
Am
J Psychiatry 162:1203-1205, June 2005
Repetitive
transcranial magnetic stimulation in schizophrenic patients reporting auditory
hallucinations
Giorgio Chibbaro,
Marco Daniele, Giovanna Alagona, Concetta Di Pasquale, Michele Cannavň,
Vincenzo Rapisarda, Rita Bella and Giovanni Pennisi
Neuroscience Letters. Volume 383, Issues 1-2, 22 July
2005-29 July 2005, Pages 54-57
Köksal Alptekin,
Şahap Erkoç, Ali K. Göğüş, Savaş Kültür, Levent Mete, Alp
Üçok and Kazım M. Yazıcı
Psychiatry Research. Volume 135, Issue 2, 15 June
2005, Pages 103-111
Pharmacological treatment and other predictors of treatment outcomes in
previously untreated patients with schizophrenia: results from the European
Schizophrenia Outpatient Health Outcomes (SOHO) study
Gasquet, Isabelle; Haro, Josep Maria;
Novick, Diego; Edgell, Eric T.; Kennedy, Liam; Lepine, Jean Pierre; on behalf
of the SOHO Study Group
International Clinical Psychopharmacology.
20(4):199-205, July 2005
Lack of
impact of race on the efficacy and safety of long-acting risperidone versus
placebo in patients with schizophrenia or schizoaffective disorder
Ciliberto, Natalie; Bossie, Cynthia A.; Urioste,
Ronald; Lasser, Robert A
International Clinical Psychopharmacology.
20(4):207-212, July 2005
Minimal
injection site pain and high patient satisfaction during treatment with
long-acting risperidone
Lindenmayer, Jean-Pierre; Jarboe, Kathleen; Bossie,
Cynthia A.; Zhu, Young; Mehnert, Angelika; Lasser, Robert
International
Clinical Psychopharmacology. 20(4):213-221, July 2005
Effects of Cigarette Smoking on Spatial Working Memory and
Attentional Deficits in Schizophrenia. Involvement of
Nicotinic Receptor Mechanisms
Kristi
A. Sacco, Angelo Termine, Aisha Seyal, Melissa M. Dudas, Jennifer C.
Vessicchio, Suchitra Krishnan-Sarin, Peter I. Jatlow, Bruce E. Wexler, Tony P.
George
Arch Gen Psychiatry. 2005;62:649-659
Changes in negative symptoms and EEG in schizophrenic patients after
repetitive Transcranial Magnetic Stimulation (rTMS): an open-label pilot study
M. Jandl,
R. Bittner, A. Sack, B. Weber, T. Günther, D. Pieschl,
W.-P. Kaschka and K. Maurer
Journal of Neural Transmission 2005; Volume 112,
Number 7: 955 - 967
Reduced prefrontal response control in patients with schizophrenias: a
subgroup analysis
J. Zielasek,
A.-C. Ehlis, M. J. Herrmann and A. J. Fallgatter
Journal of Neural Transmission 2005; Volume 112,
Number 7: 969 - 977
A meta-analysis of
worldwide studies demonstrates an association between schizophrenia and tobacco
smoking behaviors
Jose de Leon and
Francisco J. Diaz
Schizophrenia Research. Volume 76, Issues 2-3, 15 July
2005, Pages 135-157
Unchanged packing
density but altered size of neurofilament immunoreactive neurons in the
prefrontal cortex in schizophrenia and major depression
Jose Javier
Miguel-Hidalgo, Priti Dubey, Qingmei Shao, Craig Stockmeier and Grazyna
Rajkowska
Schizophrenia Research. Volume 76, Issues 2-3, 15 July
2005, Pages 159-171
The association of
the HLA in patients with schizophrenia, schizoaffective disorder, and in their
biological relatives
S.O.V. Nunes, S.D.
Borelli, T. Matsuo, M.A.E. Watanabe and E.N. Itano
Schizophrenia Research. Volume 76, Issues 2-3, 15 July
2005, Pages 195-198
Gary Remington,
Pierre Chue, Emmanuel Stip, Lili Kopala, Todd Girard and Bruce Christensen
Schizophrenia Research. Volume 76, Issues 2-3, 15 July
2005, Pages 267-272
Clinical relevance
of chronic catatonic schizophrenia in children and adolescents: Evidence from a
prospective naturalistic study
David Cohen,
Jean-Dominique Nicolas, Martine F. Flament, Didier Périsse, Pierre-François
Dubos, Olivier Bonnot, Mario Speranza, Catherine Graindorge, Sylvie Tordjman
and Philippe Mazet
Schizophrenia Research. Volume 76, Issues 2-3, 15 July
2005, Pages 301-308
Matthew Byerly,
Wayne Goodman, Wilfred Acholonu, Rhiannon Bugno and A. John Rush
Schizophrenia Research. Volume 76, Issues 2-3, 15 July
2005, Pages 309-316
GABAergic dysfunction in schizophrenia: new treatment strategies on the
horizon
Alessandro Guidotti,
James Auta, John M. Davis, Erbo Dong,
Dennis R. Grayson, Marin Veldic, Xianquan Zhang and Erminio Costa
Psychopharmacology 2005; Volume 180, Number 2: 191
- 205
Early-Onset
Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and
Extended
Stefan Leucht,
Raymonde Busch, Johannes Hamann, Werner Kissling and John M. Kane
Biological Psychiatry. Volume 57, Issue 12, 15 June 2005, Pages
1543-1549
Differences in Prolactin Elevation and Related Symptoms of
Atypical Antipsychotics in Schizophrenic Patients
Kristina Melkersson
J Clin Psychiatry 2005;66:761-767
The Cochrane
Schizophrenia Group: Preparing, maintaining and disseminating the evidence for
interventions used for people with schizophrenia
Tharyan, Prathap
International
Review of Psychiatry, April 2005, vol. 17, no. 2, pp. 115-121(7)
Yun, Yang; Phillips, Lisa J.; Cotton, Sue; Yung, Alison R.; Francey, Shona
M.; Yuen, Hok Pan; McGorry, Patrick D.
Australian and New Zealand Journal of Psychiatry, June
2005, vol. 39, no. 6, pp. 460-466(7)
Kaiser, Roland; Löhrer, Frank; Morgan, Vera; Hambrecht, Martin
Australian and New Zealand Journal of Psychiatry, June
2005, vol. 39, no. 6, pp. 467-472(6)
Nutritional
intervention to prevent weight gain in patients commenced on olanzapine: a
randomized controlled trial
Evans, Sherryn; Newton, Richard; Higgins, Sally
Australian and New Zealand Journal of Psychiatry, June
2005, vol. 39, no. 6, pp. 479-486(8)
Functional effects
of single dose first- and second-generation antipsychotic administration in
subjects with schizophrenia
Adrienne C. Lahti,
Martin A. Weiler, Deborah R. Medoff, Carol A. Tamminga and Henry H. Holcomb
Psychiatry Research:
Neuroimaging. Volume 139, Issue 1, 30 May 2005, Pages 19-30
effectiveness
of olanzapine in monotherapy: A multivariate analysis of a naturalistic study.
Ciudad A, Gutierrez M,
Canas F, Gibert J, Gascon J, Carrasco JL, Bobes J, Gomez JC, Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun 9;
[Epub ahead of print] Safety and
Older people
with chronic schizophrenia
S. Karim, R. Overshott, A.
Burns
Aging & Mental Health. Volume 9, Number 4 / July
2005: 315 - 324
Paola Rocca, Silvio
Bellino, Paolo Calvarese, Livio Marchiaro, Luca Patria, Roberta Rasetti and
Filippo Bogetto
Comprehensive Psychiatry.
Volume 46, Issue 4, July-August 2005, Pages 304-310
Amoxapine
as an Atypical Antipsychotic: A Comparative Study Vs Risperidone.
Apiquian R, Fresan A, Ulloa RE, de la Fuente-Sandoval C, Herrera-Estrella M,
Vazquez A, Nicolini H, Kapur S
Neuropsychopharmacology. 2005 Jun 8; [Epub ahead of
print]
Efficacy
of olanzapine and ziprasidone for the treatment of schizophrenia : a systematic
review
Matza LS, Baker TM, Revicki
DA
Wolfgang Aichhorn, Ulrike Weiss, Josef Marksteiner, Georg Kemmler,
Thomas Walch, Gerald Zernig, Renate Stelzig-Schoeler, Christoph Stuppaeck,
Christian Geretsegger
Journal of
Psychopharmacology, Vol. 19, No. 4, 395-401 (2005)
Samir Kumar Praharaj, Pankaj Verma, Dipayan Roy, Anuradha Singh
Journal of
Psychopharmacology, Vol. 19, No. 4, 426-428 (2005)
Clinical
improvement in 336 stable chronically psychotic patients changed from oral to
long-acting risperidone: a 12-month open trial
Robert
A. Lasser, Cynthia A. Bossie, Georges M. Gharabawi and Ross
J. Baldessarini
The International Journal of
Neuropsychopharmacology (2005), 8:3:427-438
Prediction of the
ability of clozapine to treat negative symptoms from plasma glycine and serine
levels in schizophrenia
Tomiki Sumiyoshi,
Dai Jin, Karu Jayathilake, Myung Lee and Herbert Y. Meltzer
The International Journal of
Neuropsychopharmacology (2005), 8:3:451-455
A meta-analysis of
neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone
in schizophrenia
Neil
D. Woodward, Scot E. Purdon, Herbert Y. Meltzer and David
H. Zald
The International Journal of
Neuropsychopharmacology (2005), 8:3:457-472
Jose de Leon,
Francisco J. Diaz, Richard C. Josiassen, Thomas B. Cooper and George M. Simpson
Anna E. Ordońez,
Aaron Bobb, Deanna Greenstein, Natalie Baker, Alexandra Sporn, Marge Lenane,
Dolores Malaspina, Judith Rapaport and Nitin Gogtay
Biological Psychiatry. Volume 58, Issue 1, 1 July
2005, Pages 10-15
David L. Garver,
Jennifer A. Holcomb and James D. Christensen
Biological Psychiatry. Volume 58, Issue 1, 1 July
2005, Pages 62-66